The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

被引：0
|
作者：
Heerspink, J. L. [1 ]
Wheeler, D. C. [2 ]
Vart, P. [1 ]
Jongs, N. [1 ]
Hou, F. F. [3 ]
Langkilde, A. M. [4 ]
Correa-Rotter, R. [5 ]
Rossing, P. [6 ]
Sjostrom, C. D. [4 ]
Toto, R. D. [7 ]
Chertow, G. M. [8 ]
Stefansson, B. V. [4 ]
McMurray, J. J. V. [9 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] UCL, London, England
[3] Southern Med Univ, Nanfang Hosp, Affiliated Hosp, Guangzhou, Peoples R China
[4] AstraZeneca, Gothenburg, Sweden
[5] Natl Inst Med Sci & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[6] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[7] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[8] Sch Med, Stanford, CA USA
[9] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2913 / 2913
页数：1
相关论文
共 50 条
  • [1] Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
    McMurray, John J., V
    Wheeler, David C.
    Stefansson, Bergur, V
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Hou, Fan Fan
    Rossing, Peter
    Sjostrom, C. David
    Solomon, Scott D.
    Toto, Robert D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    JACC-HEART FAILURE, 2021, 9 (11) : 807 - 820
  • [2] Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Held, Claes
    Hou, Fan-Fan
    Mann, Johannes F. E.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    CIRCULATION, 2021, 143 (05) : 438 - 448
  • [3] Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure (vol 9, 807, 2022)
    McMurray, J. J., V
    Wheeler, D. C.
    Stefansson, B., V
    Jongs, N.
    Postmus, D.
    Correa-Rotter, R.
    Chertow, G. M.
    Hou, F. F.
    Rossing, P.
    Sjostrom, C. D.
    Solomon, S. D.
    Toto, R. D.
    Langkilde, A. M.
    Heerspink, H. J. L.
    JACC-HEART FAILURE, 2022, 10 (06) : 446 - 447
  • [4] Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease
    Anjum, Deewa Zahir
    Bonde, Anders N.
    Fosbol, Emil
    Garred, Caroline Hartwell
    Gislason, Gunnar
    Elmegaard, Mariam
    Knigge, Pauline
    Torp-Pedersen, Christian
    Andersson, Charlotte
    Pfeffer, Marc A.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Petrie, Mark C.
    Kober, Lars
    Schou, Morten
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
  • [5] Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
    Gronda, Edoardo G.
    Vanoli, Emilio
    Iacoviello, Massimo
    Urbinati, Stefano
    Caldarola, Pasquale
    Colivicchi, Furio
    Gabrielli, Domenico
    HEART FAILURE REVIEWS, 2023, 28 (03) : 723 - 732
  • [6] Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
    Edoardo G. Gronda
    Emilio Vanoli
    Massimo Iacoviello
    Stefano Urbinati
    Pasquale Caldarola
    Furio Colivicchi
    Domenico Gabrielli
    Heart Failure Reviews, 2023, 28 : 723 - 732
  • [7] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
    Patoulias, Dimitrios
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (07)
  • [8] Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease
    Mann, Johannes F. E.
    Joseph, Philip
    Gao, Peggy
    Pais, Prem
    Tyrwhitt, Jessica
    Xavier, Denis
    Dans, Tony
    Jaramillo, Patricio Lopez
    Gamra, Habib
    Yusuf, Salim
    KIDNEY INTERNATIONAL, 2023, 103 (02) : 403 - 410
  • [9] Mineralocorticoid Receptor Antagonists and Renal Outcomes in Heart Failure Patients with and without Chronic Kidney Disease
    Mavrakanas, Thomas A.
    Giannetti, Nadia
    Sapir-Pichhadze, Ruth
    Alam, Ahsan
    CARDIORENAL MEDICINE, 2020, 10 (01) : 32 - 41
  • [10] Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure
    Galil, Arise G. S.
    Pinheiro, Helady S.
    Chaoubah, Alfredo
    Costa, Darcilia M. N.
    Bastos, Marcus G.
    BMC NEPHROLOGY, 2009, 10
12345